Sherwin-Williams Q3 sales rise 7.9%, EPS up slightly; full-year outlook steady amid inflation and market challenges

Sherwin-Williams reported a 7.9% increase in consolidated net sales to $6.86 billion for Q3 2026, driven by price hikes and acquisitions like Suvinil. Diluted EPS rose slightly to $3.38, with adjusted EPS up 1.1%, despite higher raw material costs and inflationary pressures. The company narrowed its full-year adjusted EPS guidance to $11.85-$12.15, maintaining sales growth expectations amid muted demand. Sherwin-Williams continues to focus on customer service, cost control, and shareholder returns, including $749 million returned in Q3 through dividends and buybacks.

Sherwin-Williams shares are trading at USD 317.00 on Pluang as of Oct 27, 2026 18:11 WIB, down 5.42% for the day. This price is closer to the 52-week low of USD 293.00 than the high of USD 372.60, indicating recent softness despite the company’s solid sales growth and shareholder returns. The dividend yield stands at 0.95%, reflecting a modest income component for investors.